Asklepios BioPharmaceutical, Inc. (AskBio)

As our friends and colleagues in the US pause to celebrate Independence Day, we’re reminded that the summer holiday season in North America and Europe provides the perfect opportunity for many of our employees to take a well-deserved break. In line with that, we instituted our “Summer Days” program, which provides #AskBio teams around the world with three additional days off that can be used between June and August. Happy 4th to everyone in the US and all the best to everybody this summer. #WorkLifeBalance  

We’re excited to share that our Chief Scientific Officer, Mansuo L Shannon, has been elected to the #AskBio Board of Directors. She brings an important perspective and expertise to the Board and will be a key voice as we continue to develop our preclinical pipeline and platform technologies. We look forward to all that Mansuo will do to ensure that AskBio continues to innovate and remain at the leading edge of science. Congratulations, Mansuo! #Leadership #GeneTherapy

At #AskBio we believe strength lies in our diversity and our Employee Resource Groups help bring this to life through ongoing educational events and campus activities. A big thank you to our LGBTQ+ Employee Resource Group for planning and hosting a series of inspiring events to celebrate Pride Month. Pride Month is a time to honor the courage, resilience, and achievements of the LGBTQ+ community. It is a celebration of diversity, love, and the ongoing fight for equality. Let’s carry forward the spirit of Pride Month and continue to raise the bar, pioneer new paths, and celebrate the vibrant tapestry of our community. Together, we are stronger, more creative, and capable of achieving extraordinary things.

“Our goal is to harness the power of gene therapy to improve patient lives globally,” Jude Samulski, co-founder and current board member of AskBio states while sharing his insights on the future of #genetherapy in a recently published article in Nature. This article shines a light on AskBio’s pioneering spirit and unwavering commitment to forging a new path where gene therapy can transform countless lives. At #AskBio, we are on the forefront of innovation, dedicated to advancing research and embracing cutting-edge science to revolutionize the field of gene therapy and make strides for a brighter future for all. Read the article (accessible with a subscription) and let us know what you think. https://lnkd.in/efQHZcmj

At #AskBio we believe strength lies in our diversity and our Employee Resource Groups (ERGs) help bring this to life through ongoing educational events and campus activities. On the eve of Juneteenth, we gathered for an informative and engaging trivia session that not only tested our knowledge but also deepened our understanding of this pivotal moment in American history. Through fun and friendly competition, we explored the origins of Juneteenth, key historical figures, and significant milestones in the journey toward freedom and equality for all. The following day, we took time off to reflect on the significance of Juneteenth. This pause allowed us to contemplate the meaning of freedom and the ongoing struggle for equality. It's a reminder of the progress we've made and the work that still lies ahead. As we carry these lessons forward, on Thursday, June 27th our African American ERG will launch our third Summer Immersion Program. The program introduces junior and senior high school students from across North Carolina to a laboratory environment and also introduces them to careers in the biopharmaceutical industry. Together, we can reimagine what is possible. #leadership #genetherapy

Today we announced the initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study assessing the efficacy and safety of AB-1005, an investigational #genetherapy for the treatment of moderate-stage Parkinson’s disease. More than 10 million people worldwide suffer from Parkinson’s disease, with approximately 1 million living in the United States. #AskBio is dedicated to advancing research and embracing cutting-edge science to explore gene therapy solutions for this debilitating disease. For Medical Media – Read our press release here: https://lnkd.in/g478gFVH #ParkinsonsDisease

This #PrideMonth, #AskBio is excited to celebrate with our LGBTQ+ colleagues and the broader community. Led by our Employee Resource Group, next week we’re hosting a series of educational events and celebrations to honor diversity, foster inclusion, and celebrate the unique identities that make our workplace vibrant and strong. Diversity is strength. Be who you are with Pride. #Pride2024

We’re excited to share the latest article from our CEO, Gustavo Pesquin, on the future of #genetherapy. #AskBio is proud to be part of the gene therapy revolution as we celebrate our milestones in #HeartFailure and #ParkinsonsDisease trials. Read more and join us for the journey. https://lnkd.in/emq7djZF

The #AskBio team recently returned from the #IAPRD2024 World Congress in Lisbon. While on site, we engaged with various experts from the movement disorder community. Our experience was capped off by a packed house for an oral presentation by our VP of Global Clinical Development, Amber Van Laar, who delivered 18-month PD safety, preliminary efficacy, and imaging data for our Phase 1b clinical trial for AB-1005, an investigational #genetherapy for treating patients with Parkinson’s disease. (For more information about the AB-1005 Phase 1b Trial, visit clinicaltrials.gov (NCT#04167540). #Parkinsonsdisease

In honor of #MentalHealthAwarenessMonth, we recognize the profound impact chronic diseases have on mental health. We recently hosted an internal event moderated by a therapist living with limb-girdle muscular dystrophy, who discussed the challenges with a panel of patients and caregivers.   Our panelists shared inspiring stories: a patient discussed her struggles with congestive heart failure and a caregiver for her husband living with the parkinsonian subtype of multiple system atrophy (MSA-P), highlighted how mental health challenges affect both patients and caregivers alike.   These stories reinforced our commitment to support those affected through our never-ending quest to advance gene therapies. #AskBio #GeneTherapy